Medifast (MED) Tops Q3 EPS by 48c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.03 --0%
EPS Growth %: -295.5%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
CCEL, FNGR, FAST, More
EPS Growth %: -295.5%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q3 EPS of $3.56, $0.48 better than the analyst estimate of $3.08. Revenue for the quarter came in at $413.4 million versus the consensus estimate of $403.76 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print
- JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
